Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07865520 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Alcohol Consumption and Plasma cfDNA Methylation in Chronic Hepatitis B

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is an observational, exploratory study designed to investigate the effect of different levels of alcohol consumption on plasma cell-free DNA (cfDNA) methylation profiles in participants with chronic hepatitis B. A total of 85 participants with chronic hepatitis B are planned to be enrolled and grouped according to their alcohol consumption status into a non-drinking group, a drinking group, and a group with alcoholic hepatitis associated with alcohol consumption. Approximately 16 mL of peripheral blood will be collected from each participant for cfDNA methylation analysis. Plasma cfDNA methylation profiles will be compared among participants with different levels of alcohol consumption to explore the effects of alcohol consumption on cfDNA methylation.
Trial Details
NCT Number NCT07865520
Lead Sponsor Beijing Municipal Administration of Hospitals
Collaborators: Qinghai Fourth People's Hospital, Peking University Shenzhen Hospital
Conditions
(from sponsor)		 Chronic Hepatitis B, Alcoholic Hepatitis
Related terms Alcohol Drinking, Hepatitis B, Chronic, Hepatitis, Alcoholic
Enrollment 85 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov